Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.25 AUD | +3.22% | -0.16% | -22.91% |
Apr. 24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
Sales 2024 * | 154M 101M | Sales 2025 * | 174M 114M | Capitalization | 2.38B 1.56B |
---|---|---|---|---|---|
Net income 2024 * | 92M 60.41M | Net income 2025 * | 96M 63.03M | EV / Sales 2024 * | 14 x |
Net cash position 2024 * | 236M 155M | Net cash position 2025 * | 344M 226M | EV / Sales 2025 * | 11.7 x |
P/E ratio 2024 * |
25.7
x | P/E ratio 2025 * |
25
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.53% |
Latest transcript on Neuren Pharmaceuticals Limited
1 day | +3.16% | ||
1 week | -0.21% | ||
Current month | -9.33% | ||
1 month | -10.55% | ||
3 months | -16.93% | ||
6 months | +84.47% | ||
Current year | -22.95% |
Managers | Title | Age | Since |
---|---|---|---|
Jon Pilcher
CEO | Chief Executive Officer | 58 | 13-08-18 |
Lauren Frazer
DFI | Director of Finance/CFO | - | 20-07-31 |
Liza Squires
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 02-03-04 | |
Dianne Angus
BRD | Director/Board Member | 63 | 18-07-04 |
Jenny Lee Harry
BRD | Director/Board Member | - | 18-07-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 773 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 19.25 | +3.22% | 366 543 |
24-04-26 | 18.65 | -1.06% | 566,651 |
24-04-24 | 18.85 | -2.33% | 266,295 |
24-04-23 | 19.3 | +0.10% | 149,881 |
24-04-22 | 19.28 | +1.90% | 234,347 |
Delayed Quote Australian S.E., April 29, 2024 at 01:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.95% | 1.55B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- NEU Stock